KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 3 filers reported holding KARUNA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 3.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,780,685 | -43.6% | 16,445 | -27.6% | 0.17% | -37.1% |
| Q2 2023 | $4,927,483 | -56.9% | 22,723 | -63.9% | 0.27% | -60.5% |
| Q1 2023 | $11,443,320 | -26.7% | 63,000 | -20.7% | 0.68% | -30.1% |
| Q4 2022 | $15,615,069 | -28.2% | 79,466 | -17.8% | 0.97% | -29.7% |
| Q3 2022 | $21,752,000 | +68.6% | 96,706 | -5.2% | 1.38% | +83.8% |
| Q2 2022 | $12,900,000 | -51.6% | 101,971 | -51.5% | 0.75% | -36.4% |
| Q1 2022 | $26,637,000 | -11.4% | 210,084 | -8.4% | 1.18% | +11.0% |
| Q4 2021 | $30,059,000 | +120.2% | 229,455 | +105.6% | 1.06% | +124.1% |
| Q3 2021 | $13,653,000 | -39.8% | 111,604 | -43.9% | 0.47% | -36.3% |
| Q2 2021 | $22,695,000 | +3.7% | 199,096 | +9.4% | 0.74% | +2.3% |
| Q1 2021 | $21,879,000 | – | 181,976 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
| Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
| First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
| Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
| MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
| PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
| Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
| Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
| Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
| CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |